Indonesia
· Delayed Price · Currency is IDR PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.26 trillion. The enterprise value is 1.04 trillion.
| Market Cap | 1.26T |
| Enterprise Value | 1.04T |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Jun 25, 2025 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding.
| Current Share Class | 448.00M |
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 9.78.
| PE Ratio | 9.78 |
| Forward PE | n/a |
| PS Ratio | 1.20 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.52 |
| P/FCF Ratio | 7.47 |
| P/OCF Ratio | 6.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.15, with an EV/FCF ratio of 6.16.
| EV / Earnings | 8.06 |
| EV / Sales | 0.99 |
| EV / EBITDA | 5.15 |
| EV / EBIT | 6.24 |
| EV / FCF | 6.16 |
Financial Position
The company has a current ratio of 5.57, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.57 |
| Quick Ratio | 2.85 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.10 |
| Interest Coverage | 44.71 |
Financial Efficiency
Return on equity (ROE) is 16.84% and return on invested capital (ROIC) is 13.28%.
| Return on Equity (ROE) | 16.84% |
| Return on Assets (ROA) | 10.52% |
| Return on Invested Capital (ROIC) | 13.28% |
| Return on Capital Employed (ROCE) | 19.08% |
| Revenue Per Employee | 2.84B |
| Profits Per Employee | 349.93M |
| Employee Count | 376 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, PT Merck Tbk has paid 35.23 billion in taxes.
| Income Tax | 35.23B |
| Effective Tax Rate | 21.48% |
Stock Price Statistics
The stock price has decreased by -26.44% in the last 52 weeks. The beta is -0.08, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | -26.44% |
| 50-Day Moving Average | 3,090.60 |
| 200-Day Moving Average | 3,410.15 |
| Relative Strength Index (RSI) | 25.05 |
| Average Volume (20 Days) | 37,635 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.05 trillion and earned 128.78 billion in profits. Earnings per share was 287.45.
| Revenue | 1.05T |
| Gross Profit | 377.12B |
| Operating Income | 166.34B |
| Pretax Income | 164.01B |
| Net Income | 128.78B |
| EBITDA | 191.16B |
| EBIT | 166.34B |
| Earnings Per Share (EPS) | 287.45 |
Balance Sheet
The company has 237.93 billion in cash and 17.31 billion in debt, giving a net cash position of 220.62 billion or 492.45 per share.
| Cash & Cash Equivalents | 237.93B |
| Total Debt | 17.31B |
| Net Cash | 220.62B |
| Net Cash Per Share | 492.45 |
| Equity (Book Value) | 829.78B |
| Book Value Per Share | 1,852.20 |
| Working Capital | 618.02B |
Cash Flow
In the last 12 months, operating cash flow was 189.22 billion and capital expenditures -20.81 billion, giving a free cash flow of 168.42 billion.
| Operating Cash Flow | 189.22B |
| Capital Expenditures | -20.81B |
| Free Cash Flow | 168.42B |
| FCF Per Share | 375.93 |
Margins
Gross margin is 36.06%, with operating and profit margins of 15.91% and 12.31%.
| Gross Margin | 36.06% |
| Operating Margin | 15.91% |
| Pretax Margin | 15.68% |
| Profit Margin | 12.31% |
| EBITDA Margin | 18.28% |
| EBIT Margin | 15.91% |
| FCF Margin | 16.11% |
Dividends & Yields
This stock pays an annual dividend of 320.00, which amounts to a dividend yield of 11.39%.
| Dividend Per Share | 320.00 |
| Dividend Yield | 11.39% |
| Dividend Growth (YoY) | -46.88% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.31% |
| Buyback Yield | n/a |
| Shareholder Yield | 11.39% |
| Earnings Yield | 10.23% |
| FCF Yield | 13.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
PT Merck Tbk has an Altman Z-Score of 8.89 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.89 |
| Piotroski F-Score | 6 |